医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)

广告
第一作者: Templeton,A.J.
作者单位: Department of Medical Oncology, Kantonsspital Luzern, Luzern, Switzerland [1] Laboratory of Tumor Immunology, Center of Oncology, University Hospital Geneva, Geneva, Switzerland [2] Institute of Surgical Pathology, University Hospital Zürich, Zürich, Switzerland [3] Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland [4] Department of Medical Oncology, University Hospital Basel, Basel, Switzerland [5] Department of Medical Oncology, University Hospital Zürich, Zürich, Switzerland [6] Department of Medical Oncology, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007 St. Gallen [7] Department of Urology, University Hospital Bern, Bern, Switzerland [8] SAKK Coordinating Center, Bern, Switzerland [9] Department of Medical Oncology, Kantonsspital Aarau, Aarau, Switzerland [10] Department of Biology, Institute of Molecular Systems Biology, Eidgen?ssische Technische Hochschule [11] Department of Medical Oncology, Spitalzentrum Biel, Biel, Switzerland [12] Department of Medical Oncology, University Hospital Bern, Bern, Switzerland [13] Department of Medical Oncology, Kantonsspital Winterthur, Winterthur, Switzerland [14]
发布时间 2013-11-20
提交
  • 浏览1
European urology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷